🟢 Achieve Life Sciences is trading 6% up in pre-market

Achieve Life Sciences is trading at $7.00, up 5.98% pre-market; no fresh company announcement explaining the move was identified.

• Achieve is set to present 52-week cytisinicline efficacy data at CHEST 2026 on October 20, 2:09–2:13 p.m. Mountain Time; the presentation was announced September 28.
• This known event is not evidence of a new overnight catalyst. XBI was reported down 3.65% pre-market, which does not explain the rise.
• No trading-volume information was provided.